Long term risk of symptomatic recurrent venous thromboembolism after discontinuation of anticoagulant treatment for first unprovoked venous thromboembolism event: systematic review and meta-analysis

Six months versus two years of oral anticoagulation after a first episode of unprovoked deep-vein thrombosis. The PADIS-DVT randomized clinical trial

(2019) Francis Couturaud et al.   HAEMATOLOGICA

Diagnosis and management of acute deep vein thrombosis: a joint consensus document from the European society of cardiology working groups of aorta and peripheral vascular diseases and pulmonary circulation and right ventricular function

(2017) Lucia Mazzolai et al.   EUROPEAN HEART JOURNAL

Rivaroxaban or Aspirin for Extended Treatment of Venous Thromboembolism

(2017) Jeffrey I. Weitz et al.   NEW ENGLAND JOURNAL OF MEDICINE

Long-term risk of recurrence after discontinuing anticoagulants for a first unprovoked venous thromboembolism: protocol for a systematic review and meta-analysis

(2017) Faizan Khan et al.   BMJ Open

Validating the HERDOO2 rule to guide treatment duration for women with unprovoked venous thrombosis: multinational prospective cohort management study

(2017) Marc A Rodger et al.   BMJ-British Medical Journal

Validating the HERDOO2 rule to guide treatment duration for women with unprovoked venous thrombosis: multinational prospective cohort management study

(2017) Marc A Rodger et al.   BMJ-British Medical Journal

Antithrombotic Therapy for VTE Disease

(2016) Clive Kearon et al.   CHEST

A risk score for prediction of recurrence in patients with unprovoked venous thromboembolism (DAMOVES)

(2016) A.I. Franco Moreno et al.   European Journal of Internal Medicine

Categorization of patients as having provoked or unprovoked venous thromboembolism: guidance from the SSC of ISTH

(2016) C. Kearon et al.   JOURNAL OF THROMBOSIS AND HAEMOSTASIS

The long-term recurrence risk of patients with unprovoked venous thromboembolism: an observational cohort study

(2016) P. A. Kyrle et al.   JOURNAL OF THROMBOSIS AND HAEMOSTASIS

Long-term risk of venous thrombosis after stopping anticoagulants for a first unprovoked event: A multi-national cohort

(2016) Marc A. Rodger et al.   THROMBOSIS RESEARCH

d-Dimer Testing to Select Patients With a First Unprovoked Venous Thromboembolism Who Can Stop Anticoagulant Therapy

(2015) Clive Kearon et al.   ANNALS OF INTERNAL MEDICINE

Six Months vs Extended Oral Anticoagulation After a First Episode of Pulmonary Embolism

(2015) Francis Couturaud et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Heterogeneity in Meta-analysis of FDG-PET Studies to Diagnose Lung Cancer

(2015) Edward J. Mills et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015: elaboration and explanation

(2015) L. Shamseer et al.   BMJ-British Medical Journal

Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015: elaboration and explanation

(2015) L. Shamseer et al.   BMJ-British Medical Journal

2014 ESC Guidelines on the diagnosis and management of acute pulmonary embolism

(2014)   EUROPEAN HEART JOURNAL

Residual Thrombosis on Ultrasonography to Guide the Duration of Anticoagulation in Patients With Deep Venous Thrombosis

(2013) Paolo Prandoni   ANNALS OF INTERNAL MEDICINE

Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement

(2013) David Moher   ANNALS OF INTERNAL MEDICINE

Systematic Review: Case-Fatality Rates of Recurrent Venous Thromboembolism and Major Bleeding Events Among Patients Treated for Venous Thromboembolism

(2013) Marc Carrier   ANNALS OF INTERNAL MEDICINE

Extended Use of Dabigatran, Warfarin, or Placebo in Venous Thromboembolism

(2013) Sam Schulman et al.   NEW ENGLAND JOURNAL OF MEDICINE

Efficacy and safety outcomes of oral anticoagulants and antiplatelet drugs in the secondary prevention of venous thromboembolism: systematic review and network meta-analysis

(2013) L. A. Castellucci et al.   BMJ-British Medical Journal

Low-Dose Aspirin for Preventing Recurrent Venous Thromboembolism

(2012) Timothy A. Brighton et al.   NEW ENGLAND JOURNAL OF MEDICINE

Aspirin for Preventing the Recurrence of Venous Thromboembolism

(2012) Cecilia Becattini et al.   NEW ENGLAND JOURNAL OF MEDICINE

Apixaban for Extended Treatment of Venous Thromboembolism

(2012) Giancarlo Agnelli et al.   NEW ENGLAND JOURNAL OF MEDICINE

Mortality and recurrence after treatment of VTE: Long term follow-up of patients with good life-expectancy

(2011) Marianne S. Andresen et al.   THROMBOSIS RESEARCH

Risk of Recurrence After a First Episode of Symptomatic Venous Thromboembolism Provoked by a Transient Risk Factor

(2010) Alfonso Iorio et al.   ARCHIVES OF INTERNAL MEDICINE

Patients with a first symptomatic unprovoked deep vein thrombosis are at higher risk of recurrent venous thromboembolism than patients with a first unprovoked pulmonary embolism

(2010) M. J. KOVACS et al.   JOURNAL OF THROMBOSIS AND HAEMOSTASIS

Oral Rivaroxaban for Symptomatic Venous Thromboembolism

(2010)   NEW ENGLAND JOURNAL OF MEDICINE

Identifying unprovoked thromboembolism patients at low risk for recurrence who can discontinue anticoagulant therapy

(2008) M. A. Rodger et al.   CANADIAN MEDICAL ASSOCIATION JOURNAL